Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Johnson & Johnson’s entry into the PARP inhibitor market with prostate cancer therapy Akeega has started with a disappointing ruling in the EU. The EMA’s human medicines committee has recommended ...